vs

Side-by-side financial comparison of Invesco (IVZ) and Synopsys (SNPS). Click either name above to swap in a different company.

Synopsys is the larger business by last-quarter revenue ($2.3B vs $1.7B, roughly 1.3× Invesco). Synopsys runs the higher net margin — 19.9% vs -58.9%, a 78.8% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs 6.2%). Synopsys produced more free cash flow last quarter ($605.2M vs $432.2M). Over the past eight quarters, Synopsys's revenue compounded faster (16.9% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.

IVZ vs SNPS — Head-to-Head

Bigger by revenue
SNPS
SNPS
1.3× larger
SNPS
$2.3B
$1.7B
IVZ
Growing faster (revenue YoY)
SNPS
SNPS
+44.3% gap
SNPS
50.6%
6.2%
IVZ
Higher net margin
SNPS
SNPS
78.8% more per $
SNPS
19.9%
-58.9%
IVZ
More free cash flow
SNPS
SNPS
$173.0M more FCF
SNPS
$605.2M
$432.2M
IVZ
Faster 2-yr revenue CAGR
SNPS
SNPS
Annualised
SNPS
16.9%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVZ
IVZ
SNPS
SNPS
Revenue
$1.7B
$2.3B
Net Profit
$-995.9M
$448.7M
Gross Margin
71.0%
Operating Margin
-86.2%
5.4%
Net Margin
-58.9%
19.9%
Revenue YoY
6.2%
50.6%
Net Profit YoY
-575.8%
-59.7%
EPS (diluted)
$-2.61
$2.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
SNPS
SNPS
Q4 25
$1.7B
$2.3B
Q3 25
$1.6B
$1.7B
Q2 25
$1.5B
$1.6B
Q1 25
$1.5B
$1.5B
Q4 24
$1.6B
$1.5B
Q3 24
$1.5B
$1.5B
Q2 24
$1.5B
$1.5B
Q1 24
$1.5B
$1.6B
Net Profit
IVZ
IVZ
SNPS
SNPS
Q4 25
$-995.9M
$448.7M
Q3 25
$356.4M
$242.5M
Q2 25
$197.4M
$345.3M
Q1 25
$171.1M
$295.7M
Q4 24
$209.3M
$1.1B
Q3 24
$55.0M
$408.1M
Q2 24
$132.2M
$292.1M
Q1 24
$141.5M
$449.1M
Gross Margin
IVZ
IVZ
SNPS
SNPS
Q4 25
71.0%
Q3 25
78.1%
Q2 25
80.2%
Q1 25
81.4%
Q4 24
78.3%
Q3 24
80.9%
Q2 24
79.4%
Q1 24
80.0%
Operating Margin
IVZ
IVZ
SNPS
SNPS
Q4 25
-86.2%
5.4%
Q3 25
16.5%
9.5%
Q2 25
14.1%
23.5%
Q1 25
18.1%
17.3%
Q4 24
19.6%
20.3%
Q3 24
6.6%
23.6%
Q2 24
13.9%
22.8%
Q1 24
14.4%
21.8%
Net Margin
IVZ
IVZ
SNPS
SNPS
Q4 25
-58.9%
19.9%
Q3 25
21.7%
13.9%
Q2 25
13.0%
21.5%
Q1 25
11.2%
20.3%
Q4 24
13.1%
74.4%
Q3 24
3.6%
26.7%
Q2 24
8.9%
20.1%
Q1 24
9.6%
27.2%
EPS (diluted)
IVZ
IVZ
SNPS
SNPS
Q4 25
$-2.61
$2.44
Q3 25
$0.66
$1.50
Q2 25
$-0.03
$2.21
Q1 25
$0.38
$1.89
Q4 24
$0.46
$7.13
Q3 24
$0.12
$2.61
Q2 24
$0.29
$1.88
Q1 24
$0.31
$2.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
SNPS
SNPS
Cash + ST InvestmentsLiquidity on hand
$1.0B
$3.0B
Total DebtLower is stronger
$1.8B
$13.5B
Stockholders' EquityBook value
$12.2B
$28.3B
Total Assets
$27.1B
$48.2B
Debt / EquityLower = less leverage
0.15×
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
SNPS
SNPS
Q4 25
$1.0B
$3.0B
Q3 25
$973.1M
$2.6B
Q2 25
$922.7M
$14.3B
Q1 25
$821.7M
$3.8B
Q4 24
$986.5M
$4.1B
Q3 24
$1.0B
$2.0B
Q2 24
$878.5M
$1.7B
Q1 24
$895.7M
$1.3B
Total Debt
IVZ
IVZ
SNPS
SNPS
Q4 25
$1.8B
$13.5B
Q3 25
$1.6B
$14.3B
Q2 25
$1.9B
$10.1B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
IVZ
IVZ
SNPS
SNPS
Q4 25
$12.2B
$28.3B
Q3 25
$14.0B
$27.6B
Q2 25
$13.9B
$9.9B
Q1 25
$14.7B
$9.3B
Q4 24
$14.6B
$9.0B
Q3 24
$14.8B
$7.7B
Q2 24
$14.6B
$7.2B
Q1 24
$14.6B
$6.7B
Total Assets
IVZ
IVZ
SNPS
SNPS
Q4 25
$27.1B
$48.2B
Q3 25
$28.4B
$48.2B
Q2 25
$28.5B
$23.8B
Q1 25
$28.1B
$13.0B
Q4 24
$27.0B
$13.1B
Q3 24
$27.5B
$11.6B
Q2 24
$27.2B
$11.0B
Q1 24
$28.1B
$10.6B
Debt / Equity
IVZ
IVZ
SNPS
SNPS
Q4 25
0.15×
0.48×
Q3 25
0.12×
0.52×
Q2 25
0.14×
1.01×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
SNPS
SNPS
Operating Cash FlowLast quarter
$455.8M
$639.7M
Free Cash FlowOCF − Capex
$432.2M
$605.2M
FCF MarginFCF / Revenue
25.5%
26.8%
Capex IntensityCapex / Revenue
1.4%
1.5%
Cash ConversionOCF / Net Profit
1.43×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
SNPS
SNPS
Q4 25
$455.8M
$639.7M
Q3 25
$606.2M
$671.0M
Q2 25
$547.9M
$275.4M
Q1 25
$-84.6M
$-67.5M
Q4 24
$316.9M
$562.8M
Q3 24
$438.4M
$455.4M
Q2 24
$489.1M
$476.6M
Q1 24
$-54.4M
$-87.8M
Free Cash Flow
IVZ
IVZ
SNPS
SNPS
Q4 25
$432.2M
$605.2M
Q3 25
$586.4M
$632.4M
Q2 25
$530.4M
$219.8M
Q1 25
$-108.0M
$-108.2M
Q4 24
$309.9M
$558.4M
Q3 24
$410.0M
$415.4M
Q2 24
$462.4M
$438.2M
Q1 24
$-75.4M
$-128.2M
FCF Margin
IVZ
IVZ
SNPS
SNPS
Q4 25
25.5%
26.8%
Q3 25
35.7%
36.3%
Q2 25
35.0%
13.7%
Q1 25
-7.1%
-7.4%
Q4 24
19.5%
37.3%
Q3 24
27.1%
27.2%
Q2 24
31.2%
30.1%
Q1 24
-5.1%
-7.8%
Capex Intensity
IVZ
IVZ
SNPS
SNPS
Q4 25
1.4%
1.5%
Q3 25
1.2%
2.2%
Q2 25
1.2%
3.5%
Q1 25
1.5%
2.8%
Q4 24
0.4%
0.3%
Q3 24
1.9%
2.6%
Q2 24
1.8%
2.6%
Q1 24
1.4%
2.4%
Cash Conversion
IVZ
IVZ
SNPS
SNPS
Q4 25
1.43×
Q3 25
1.70×
2.77×
Q2 25
2.78×
0.80×
Q1 25
-0.49×
-0.23×
Q4 24
1.51×
0.51×
Q3 24
7.97×
1.12×
Q2 24
3.70×
1.63×
Q1 24
-0.38×
-0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

SNPS
SNPS

License And Maintenance$940.7M42%
Other$640.0M28%
Design IP Segment$407.1M18%
KR$236.9M11%
Sales Based Royalties$30.1M1%

Related Comparisons